SRS Capital Advisors Inc. Purchases 250 Shares of Danaher Co. (NYSE:DHR)

SRS Capital Advisors Inc. grew its position in shares of Danaher Co. (NYSE:DHR) by 3.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,829 shares of the conglomerate’s stock after acquiring an additional 250 shares during the quarter. SRS Capital Advisors Inc.’s holdings in Danaher were worth $1,811,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. Wellington Management Group LLP grew its holdings in Danaher by 18.6% during the third quarter. Wellington Management Group LLP now owns 24,930,281 shares of the conglomerate’s stock worth $6,185,203,000 after purchasing an additional 3,905,449 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Danaher by 6.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 8,183,501 shares of the conglomerate’s stock worth $2,030,327,000 after acquiring an additional 502,868 shares during the period. Northern Trust Corp increased its holdings in shares of Danaher by 1.7% during the 3rd quarter. Northern Trust Corp now owns 8,100,722 shares of the conglomerate’s stock worth $2,009,789,000 after acquiring an additional 134,905 shares during the last quarter. Flossbach Von Storch AG raised its stake in Danaher by 1.8% in the 4th quarter. Flossbach Von Storch AG now owns 4,601,351 shares of the conglomerate’s stock valued at $1,064,477,000 after acquiring an additional 82,672 shares during the period. Finally, Fisher Asset Management LLC lifted its holdings in Danaher by 6.2% during the 4th quarter. Fisher Asset Management LLC now owns 4,227,108 shares of the conglomerate’s stock valued at $977,900,000 after purchasing an additional 248,140 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

NYSE DHR traded down $0.69 during trading hours on Thursday, reaching $246.20. The company’s stock had a trading volume of 1,023,314 shares, compared to its average volume of 2,758,876. The company has a quick ratio of 1.51, a current ratio of 1.85 and a debt-to-equity ratio of 0.31. Danaher Co. has a 1 year low of $182.09 and a 1 year high of $259.00. The firm’s 50-day moving average price is $248.71 and its 200-day moving average price is $231.90. The company has a market capitalization of $182.36 billion, a price-to-earnings ratio of 41.85, a PEG ratio of 3.80 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.62 billion. During the same period in the previous year, the firm posted $2.36 EPS. Danaher’s revenue for the quarter was down 2.6% compared to the same quarter last year. On average, equities research analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Shareholders of record on Thursday, March 28th were paid a $0.27 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date was Wednesday, March 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s payout ratio is presently 18.31%.

Insider Transactions at Danaher

In other Danaher news, SVP Georgeann Couchara sold 2,622 shares of Danaher stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total value of $636,280.74. Following the completion of the transaction, the senior vice president now directly owns 4,244 shares of the company’s stock, valued at approximately $1,029,891.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Brian W. Ellis sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $250.01, for a total value of $1,000,040.00. Following the completion of the sale, the senior vice president now owns 29,830 shares in the company, valued at approximately $7,457,798.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Georgeann Couchara sold 2,622 shares of the company’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total transaction of $636,280.74. Following the transaction, the senior vice president now owns 4,244 shares in the company, valued at $1,029,891.48. The disclosure for this sale can be found here. Insiders have sold 106,565 shares of company stock valued at $26,641,364 in the last ninety days. Corporate insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on DHR shares. HSBC upgraded shares of Danaher from a “hold” rating to a “buy” rating and raised their target price for the stock from $250.00 to $280.00 in a research note on Wednesday, April 17th. KeyCorp increased their target price on Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a research note on Thursday, February 1st. Royal Bank of Canada boosted their price target on Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Citigroup lifted their target price on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Finally, StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, January 31st. Six investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $267.31.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.